Showing results (11-20 of 68) with videos related to
Sort By:
Pageof 7
Oncotarget|May 26, 2016
FAM83 proteins: Fostering new interactions to drive oncogenic signaling and therapeutic resistanceCourtney A Bartel, Neetha Parameswaran, Rocky Cipriano, et al.Cancer Biology & Therapy|October 26, 2013
ETV1 positively regulates transcription of tumor suppressor ARFEvan Zynda, Mark W Jackson, Partho Bhattacharya, et al.Cancer Research|October 1, 2009
Overexpression of kinesins mediates docetaxel resistance in breast cancer cellsSarmishtha De, Rocky Cipriano, Mark W Jackson, et al.Cell Cycle (Georgetown, Tex.)|March 23, 2010
Inactivation of p53 signaling by p73 or PTEN ablation results in a transformed phenotype that remains susceptible to Nutlin-3 mediated apoptosisRocky Cipriano, John T Patton, Lindsey D Mayo, et al.Cell Cycle (Georgetown, Tex.)|November 29, 2016
STAT3-mediated SMAD3 activation underlies Oncostatin M-induced SenescenceBenjamin L Bryson, Damian J Junk, Rocky Cipriano, et al.Cancers|January 8, 2016
Cancer Stem Cell Plasticity Drives Therapeutic ResistanceMary R Doherty, Jacob M Smigiel, Damian J Junk, et al.Journal of Environmental Management|January 5, 2007
The effects of sediment-laden waters on irrigated lands along the lower Yellow River in ChinaQin Mingzhou, Richard H Jackson, Yuan Zhongjin, et al.Cancer Research|October 19, 2007
p53-mediated growth suppression in response to Nutlin-3 in cyclin D1 transformed cells occurs independently of p21Charlene E Kan, John T Patton, George R Stark, et al.The Journal of Pathology|February 24, 2018
Breaking the oncostatin M feed-forward loop to suppress metastasis and therapy failureJacob Smigiel, Jenny G Parvani, Ilaria Tamagno, et al.Trends in Cancer|October 10, 2022
How cancer cells make and respond to interferon-IHyeonJoo Cheon, Yuxin Wang, Samantha M Wightman, et al.Pageof 7